"Nanomedicines For Treatment Of Disease" in Patent Application Approval Process (USPTO 20240050420).
In: Clinical Trials Week, 2024-03-05, S. 2679-2679
serialPeriodical
Zugriff:
A patent application has been filed for the development of nanomedicines to treat polycystic kidney disease (PKD). The application proposes the use of nanoparticles loaded with rapamycin and/or an antioxidant called TEMPO, which would be targeted specifically to the kidneys using folate conjugation. The nanomedicines aim to reduce side effects and increase drug efficacy compared to current treatments. The patent application provides detailed information on the formulation and administration of these nanoparticulate formulations for the treatment of chronic kidney diseases. [Extracted from the article]
Copyright of Clinical Trials Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Nanomedicines For Treatment Of Disease" in Patent Application Approval Process (USPTO 20240050420).
|
---|---|
Zeitschrift: | Clinical Trials Week, 2024-03-05, S. 2679-2679 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6772 (print) |
Schlagwort: |
|
Sonstiges: |
|